• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Bioretec

0.02 EUR

-3.60 %

1,791 following

BRETEC

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-3.60 %
+69.84 %
-14.71 %
-61.19 %
-66.93 %
-87.75 %
-89.91 %
-
-91.73 %

Bioretec operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other materials for bone and soft tissue injuries. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic region.

Read more
Market cap
28.71M EUR
Turnover
145.78K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Accumulate
Target price
Updated
18.05.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Stock Exchange Release Bioretec Ltd - Managers’ Transactions - Paavola May 18, 2026 at 1:45 p.m. Person subject to the notification requirement Name: Tuukka Paavola Position: Chief Financial Officer (CFO) Nature of the transaction: ACQUISITION Transaction details (1): Volume: 500...
5/18/2026, 10:49 AM
by Index
15
Stock Exchange Release Bioretec Ltd - Managers’ Transactions - Jordy Winters Bioretec Ltd Company Release 2 June 2026 at 1:25 p.m. EEST Person subject to the notification requirement Name: Jordy Winters Position: Other senior management Nature of the transaction: ACQUISITION Volume...
5 hours ago
by Index
11
That came right on cue!
5/18/2026, 7:48 AM
by BossoB
11
A 200 million euro balance sheet and a 100% equity ratio. His previous company, Picosun, was sold for hundreds of millions, which is the source of the company’s significant wealth.
5/21/2026, 7:40 AM
by Roni
7
Since biodegradable screws eliminate the need for removal surgery, it can be assumed that the number of complications will decrease, based on the premise that surgeries in general always carry a risk of complications. The US market operates primarily on a fee-for-service basis as...
5/22/2026, 12:59 PM
by Matti
6
Today’s newspaper Kaleva features an article on robotic surgery at OYS (Oulu University Hospital), and below is a screenshot from the piece. These are the reasons why, just over a year ago, Bioretec was the largest position in my portfolio and why I participated in last summer’s ...
5/22/2026, 12:16 PM
by Matti
3
Yeah, I have to open my mouth as well, since I’ve been following this since the early days of the FDA clearance application. The offering ended up being quite successful and the share price has started a slight upward trend. Personally, I have very mixed feelings about the share ...
5/23/2026, 10:59 PM
by Valle
2
Read more on our forum
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 18.05.2026

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.8.
2026

Interim report Q2'26

12.11.
2026

Business review Q3'26

Regulatory press release6 hours ago

Bioretec Ltd - Manager's transactions - Jordy Winters

Bioretec
Bioretec seeks additional savings through change negotiations
Analyst Comment9 hours ago by
Antti Siltanen

Bioretec seeks additional savings through change negotiations

The company is seeking additional savings of 0.2 MEUR, as production capacity is still too high relative to demand.

Bioretec
Regulatory press releaseyesterday

The Board of Directors of Bioretec Ltd resolved on a new stock option plan

Bioretec

Join Inderes community

Research, tools and community to support better investment decisions.

FREE account
The market's most popular morning review
Analysts' recommendations and comments
Stock comparison and the investor discussion forum
PREMIUM account
All company reports and analyses
Premium content: model portfolio, insider transactions, Premium articles
Inderes MCP: Inderes data directly into your AI tools
Create account
Regulatory press releaseyesterday

Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency

Bioretec
Regulatory press release5/18/2026, 10:45 AM

Bioretec Ltd - Managers' transactions - Paavola

Bioretec
Bioretec Q1'26: The beginning of the year offered positive signs7:09
Video5/18/2026, 7:45 AM by
Antti Siltanen

Bioretec Q1'26: The beginning of the year offered positive signs

Bioretec's Q1 earnings positively surprised in terms of revenue and profit, particularly due to growth in the US and European markets.

Bioretec
Bioretec Q1'26: Early signs of growth emerging
Research5/18/2026, 7:25 AM by
Antti Siltanen

Bioretec Q1'26: Early signs of growth emerging

Bioretec's start to the year offered a positive surprise.

Bioretec
Regulatory press release5/15/2026, 6:00 AM

Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy

Bioretec
Regulatory press release5/13/2026, 11:00 AM

Bioretec clarifies its 2026-2028 financial target regarding the sales margin

Bioretec
Bioretec Q1'26 preview: Initiating RemeOs sales in Europe
Analyst Comment5/12/2026, 6:46 AM by
Antti Siltanen

Bioretec Q1'26 preview: Initiating RemeOs sales in Europe

In the report, our attention is drawn to the development of RemeOs sales in Europe and the United States.

Bioretec
Regulatory press release5/8/2026, 5:40 PM

Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors

Bioretec
Regulatory press release5/8/2026, 11:45 AM

Bioretec Ltd's resolutions of the Annual General Meeting

Bioretec
Regulatory press release4/29/2026, 1:40 PM

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö)

Bioretec
Bioretec: Successful share issue to drive new growth
Research4/29/2026, 7:17 AM by
Antti Siltanen

Bioretec: Successful share issue to drive new growth

The share issue secures funding at least until mid-2027.

Bioretec
Regulatory press release4/28/2026, 1:55 PM

Bioretec Ltd - Manager's transactions - Stephen Industries Inc Oy

Bioretec
Regulatory press release4/28/2026, 12:55 PM

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Kustaa Poutiainen)

Bioretec
Regulatory press release4/28/2026, 10:40 AM

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue

Bioretec
Regulatory press release4/28/2026, 10:10 AM

New shares of Bioretec Ltd registered with the trade register

Bioretec
Regulatory press release4/27/2026, 1:00 PM

Bioretec Ltd - Manager's transactions - Paavola

Bioretec
Regulatory press release4/24/2026, 3:45 PM

Final results of Bioretec Ltd's rights issue

Bioretec